Vespa Edoardo, Pellegatta Gaia, Chandrasekar Viveksandeep T, Spadaccini Marco, Patel Harsh, Maselli Roberta, Galtieri Piera A, Carlani Elisa, Sharma Prateek, Hassan Cesare, Repici Alessandro
Department of Gastroenterology and Hepatology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Endoscopy. 2023 Feb;55(2):167-175. doi: 10.1055/a-1894-0147. Epub 2022 Jul 7.
The long-term outcomes of esophageal peroral endoscopic myotomy (POEM) are still unknown.
We searched electronic databases (MEDLINE/PubMed, EMBASE, Scopus) for studies assessing outcomes after POEM for esophageal achalasia with a minimum median follow-up duration of 36 months. Pooled rates of clinical success and postoperative reflux were calculated and compared with the same values at 12/24/36 months when available. Subgroup analyses were performed to explore the interstudy heterogeneity.
From 1528 initial records, 11 studies (2017-2021) were included. A total of 2342 patients (age 48.1 [SD 6.8] years; 50.1 % males) with a median follow-up of 48 months (interquartile range 45-60) were analyzed. The pooled clinical success rate was 87.3 % (95 %CI 83.6 %-91.0 %; = 73.1 %). The symptomatic reflux pooled rate was 22.0 % (95 %CI 14.4 %-29.5 %; = 92.7 %). Three cases of peptic strictures and one Barrett's esophagus were reported. The pooled rate of severe adverse events was 1.5 % (95 %CI 0.5 %-2.5 %; = 52.8 %).
Long-term clinical efficacy of POEM persisted in 87 % of patients with achalasia. Post-POEM symptomatic reflux remained stable over time. The risk for Barrett's esophagus and peptic strictures appeared minimal.
经口内镜下食管肌切开术(POEM)的长期疗效尚不清楚。
我们检索了电子数据库(MEDLINE/PubMed、EMBASE、Scopus),以查找评估POEM治疗贲门失弛缓症后疗效的研究,这些研究的最短中位随访时间为36个月。计算临床成功率和术后反流的合并率,并与12/24/36个月时的相同值(如有)进行比较。进行亚组分析以探讨研究间的异质性。
从1528条初始记录中,纳入了11项研究(2017 - 2021年)。共分析了2342例患者(年龄48.1[标准差6.8]岁;男性占50.1%),中位随访时间为48个月(四分位间距45 - 60)。合并临床成功率为87.3%(95%置信区间83.6% - 91.0%;I² = 73.1%)。有症状反流的合并率为22.0%(95%置信区间14.4% - 29.5%;I² = 92.7%)。报告了3例消化性狭窄和1例巴雷特食管。严重不良事件的合并率为1.5%(95%置信区间0.5% - 2.5%;I² = 52.8%)。
POEM对87%的贲门失弛缓症患者具有长期临床疗效。POEM术后有症状反流随时间保持稳定。巴雷特食管和消化性狭窄的风险似乎极小。